NorthWest Biotherapeutics Inc (NWBO)

[lrdpdx77]

I agree with what you're saying and I think a SP of $5 to $10 would reflect a great deal of speculative value pre-approval. I think SP after approval could easily be $20 or greater. Now if TLD/Publication results leads significant parts of the market to assign a higher probability to approval then my initial $5 to $10 range is too low. I feel pretty strongly that we should be have some RA approvals by June 2022 so I expect the price to be in the higher ranges ($20 plus) for the second half of 2022.